DocuSign, Inc. (NASDAQ:DOCU) Insider Sells $820,752.54 in Stock

by · The Markets Daily

DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) insider Robert Chatwani sold 14,799 shares of DocuSign stock in a transaction that occurred on Wednesday, September 18th. The stock was sold at an average price of $55.46, for a total transaction of $820,752.54. Following the sale, the insider now owns 70,748 shares of the company’s stock, valued at approximately $3,923,684.08. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Robert Chatwani also recently made the following trade(s):

  • On Monday, June 24th, Robert Chatwani sold 14,799 shares of DocuSign stock. The shares were sold at an average price of $52.17, for a total transaction of $772,063.83.

DocuSign Trading Up 0.1 %

Shares of NASDAQ DOCU opened at $57.97 on Friday. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76. The firm has a market capitalization of $11.87 billion, a price-to-earnings ratio of 111.48, a PEG ratio of 5.99 and a beta of 0.93. The business has a 50-day moving average of $55.87 and a 200-day moving average of $56.17.

DocuSign (NASDAQ:DOCU – Get Free Report) last issued its quarterly earnings data on Thursday, September 5th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.80 by $0.17. The company had revenue of $736.03 million during the quarter, compared to analyst estimates of $727.20 million. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. DocuSign’s revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.09 earnings per share. On average, analysts predict that DocuSign, Inc. will post 0.99 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have issued reports on DOCU. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, September 6th. Robert W. Baird upped their price objective on shares of DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Piper Sandler decreased their price objective on shares of DocuSign from $65.00 to $60.00 and set a “neutral” rating on the stock in a report on Friday, June 7th. JMP Securities reiterated a “market outperform” rating and issued a $84.00 price objective on shares of DocuSign in a report on Thursday, September 5th. Finally, Bank of America upped their price objective on shares of DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $61.45.

Get Our Latest Research Report on DOCU

Institutional Trading of DocuSign

Several hedge funds and other institutional investors have recently bought and sold shares of DOCU. Comerica Bank raised its holdings in shares of DocuSign by 228.8% during the first quarter. Comerica Bank now owns 28,901 shares of the company’s stock valued at $1,721,000 after acquiring an additional 20,110 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of DocuSign by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 21,399,739 shares of the company’s stock valued at $1,272,214,000 after acquiring an additional 417,352 shares in the last quarter. KBC Group NV raised its holdings in shares of DocuSign by 119.3% during the fourth quarter. KBC Group NV now owns 739,196 shares of the company’s stock valued at $43,945,000 after acquiring an additional 402,084 shares in the last quarter. Retirement Systems of Alabama bought a new position in shares of DocuSign during the first quarter valued at approximately $8,700,000. Finally, PGGM Investments raised its holdings in shares of DocuSign by 36.7% during the second quarter. PGGM Investments now owns 49,812 shares of the company’s stock valued at $2,665,000 after acquiring an additional 13,379 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories